GlaxoSmithKline
GSK
$35.08
Share price
0.11%
Change (1 day)
-19.11%
Change (1 year)
Categories
EPS for GlaxoSmithKline (GSK)
EPS in 2022 (TTM): $7.91
According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $7.91. In 2021 the company made an earnings per share (EPS) of $2.99 a decrease over its 2020 EPS that were of $3.64.
EPS history for GlaxoSmithKline from 2011 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $7.91 | 164.2% |
| 2021 | $2.99 | -17.83% |
| 2020 | $3.64 | 21.82% |
| 2019 | $2.99 | 23.91% |
| 2018 | $2.41 | 141.48% |
| 2017 | $1.00 | 64.6% |
| 2016 | $0.61 | -90.64% |
| 2015 | $6.48 | 178.14% |
| 2014 | $2.33 | -48.16% |
| 2013 | $4.50 | 21.31% |
| 2012 | $3.71 | -10.35% |
| 2011 | $4.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.19 | -59.65% | 🇨🇭 Switzerland |
 Pfizer PFE | $5.60 | -29.17% | 🇺🇸 USA |
 Sanofi SNY | $2.85 | -64.02% | 🇫🇷 France |
 Merck MRK | $5.73 | -27.53% | 🇺🇸 USA |
 AstraZeneca AZN | $1.06 | -86.59% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.12 | -126.81% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $2.31 | -70.78% | 🇺🇸 USA |